Nigeria

in page functions
[French]
Nigeria
Total population (2018) 196,752,811
Birth cohort (2018) 7,417,798
Surviving Infants (surviving to 1 year per year, 2018) 6,922,833
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 69/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 109/1000
World Bank Index, IDA (2015) 3.41
Gross Nation Income (per capita US$, 2015) 2,820
Co-financing group (2018) Accelerated transition
No. of districts/territories (2017) 774

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Nigeria

Type of support

Approvals

2001-2023 (US$)
(26 Dec 2018)

Commitments

2001-2023 (US$)
(26 Dec 2018)

Disbursements

2000-2018 (US$)
(26 Dec 2018)

% Disbursed

(26 Dec 2018)
2001 2002 2003 2004 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $912,274,825 $991,718,825 $837,105,661
Health system strengthening (HSS 1) $32,562,282 $32,562,282 $30,297,040 93%
Immunisation services support (ISS) $44,407,837 $44,407,837 $44,162,306 99%
Injection Safety Devices (NVS) $8,051,500 $8,776,000 $4,617,324 57%
Injection safety support (INS) $12,630,270 $12,630,270 $12,610,218 100%
IPV (NVS) $60,582,592 $60,582,592 $41,309,309 68%
Measles SIA (NVS) $22,491,870 $22,491,870 $22,604,288 100%
Measles SIA - Operational costs (OPC) $37,207,046 $37,207,046 $37,207,046 100%
Measles-Follow-up campaign (NVS) $11,209,500 $11,209,500 $11,458,257 102%
Measles-Follow-up campaign op.costs (OPC) $15,703,035 $15,703,035 $15,699,648 100%
Meningitis A (NVS) $6,016,000 $10,582,500 $6,257,724 104%
Meningitis A - campaign (NVS) $55,966,777 $55,966,777 $56,057,711 100%
Meningitis A - mini catch-up campaign (NVS) $21,044,000 $21,044,000 $22,057,844 105%
Meningitis A - mini catch-up op.costs (OPC) $14,409,590 $14,409,590
Meningitis A - operational costs (OPC) $43,505,648 $43,505,648 $43,505,648 100%
Penta (NVS) $146,610,194 $148,900,694 $145,916,719 100%
Pneumo (NVS) $228,214,642 $249,289,142 $224,168,622 98%
Product Switch Grant (PSG) $2,049,376 $2,049,376 $1,186,848 58%
Rotavirus (NVS) $50,788,000 N/A
Vaccine Introduction Grant (VIG) $20,928,337 $20,928,337 $14,176,839 68%
Yellow Fever (NVS) $39,012,946 $39,012,946 $39,711,793 102%
Yellow Fever - campaign (NVS) $71,099,883 $71,099,883 $46,351,179 65%
YF - Operational costs (OPC) $18,571,500 $18,571,500 $17,749,298 96%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nigeria DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 33%
M:F sex ratio at birth (2018) 1.06
Household survey: DTP3 coverage for male (2012) 39.40%
Household survey: DTP3 coverage for female (2012) 37.00%
Household survey: Last DTP3 survey (2012) 38%
% districts achieving > 80% DTP3 coverage (2017) 88%
% districts achieving < 50% DTP3 coverage (2017) 2%
MCV WHO/UNICEF estimates (2017) 42%

Breakdown of support

Non-vaccine support Vaccine support
26% 74%
$216,594,891 $620,510,770

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nigeria

13 February 2019

Gavi default item

UK to host Gavi replenishment in 2020

Pledging conference will raise funds for 2021-25 period .

10 December 2018

Gavi item

South Korea pledges US$15 million to immunise children in world's poorest countries

New funding will help Gavi, the Vaccine Alliance, vaccinate millions of children against deadly diseases.

29 November 2018

Gavi item

Gavi Board starts framing Alliance's approach to 2021-2025 period

Gavi Board approves in principle a set of new and expanded vaccine programmes.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here